查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790233

HSV 检测市场规模、份额和趋势分析（按类型、检测类型、样本类型、最终用途、地区和细分市场预测），2025 年至 2033 年

HSV Testing Market Size, Share & Trends Analysis By Type, By Test Type, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

HSV检测市场概述

2024 年全球 HSV 检测市场规模估计为 6.1197 亿美元，预计到 2033 年将达到 10.1775 亿美元，2025 年至 2033 年的复合年增长率为 5.96%。该市场包括旨在及时可靠地检测 1 型和 2 型单纯疱疹病毒的诊断解决方案。

该领域的检测平台涵盖从传统血清学方法到先进的分子检测，旨在支援各种医疗环境中的临床决策。这些解决方案主要用于性行为感染传染病管理和产前筛检，并在分散式和照护现场中日益广泛的应用。单纯疱疹病毒感染疾病的上升，加上公众意识的提高和改善性健康筛检的努力，正在推动市场扩张。单纯疱疹病毒检测与数位平台和远距离诊断工具的整合，进一步扩大了医疗服务的可及性，尤其是在资源匮乏和服务不足的地区，从而能够更早发现并及时进行临床干预。

分子诊断技术的持续进步正在提高 HSV 检测的敏感度和周转时间。能够同时检测 HSV 和其他性行为感染病原体的多重 PCR 平台正逐渐成为临床的首选，尤其是在门诊病人和急诊护理机构。此外，改善「检体到结果」工作流程的新型检测套组已获得监管机构的核准，这支持了其在基层医疗和急诊护理机构中的应用。

政府加大对性传染感染监测和预防计画的投入和投入也促进了市场的成长。公共卫生宣传活动，尤其是针对青少年和生殖健康的宣传活动，正在推动对便利且准确的单纯疱疹病毒检测的需求。公共卫生机构与私人诊断机构之间的开发合作正在扩大检测的可近性，有助于缩小已开发国家和资源匮乏地区的诊断差距。

目录

第 1 章 HSV 检视市场：调查方法与范围

第 2 章：HSV 检查市场 -执行摘要

  • 市场概述
  • 类型和测试类型简介
  • 样本类型简介
  • 最终用途简介
  • 竞争格局简介

第 3 章 HSV 检视市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 全球 HSV 感染率上升
    • 分子和就地检验技术的进步
    • 公共卫生倡议和定期性行为感染传染病检测计划
  • 市场限制因素分析
    • 血清学检测的诊断准确性有限
    • 与 HSV 感染相关的耻辱感和漏报
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第 4 章：HSV 检视市场类型、估计与趋势分析

  • HSV检测市场：类型变化分析
  • 混合性 HSV-1/HSV-2
  • HSV-1
  • HSV-2

第 5 章：HSV 测试市场：按测试类型估算和趋势分析

  • HSV 测试市场：测试类型变化分析
  • 血清学检测
  • 直接检测试验
    • PCR
    • 病毒培养
  • 就地检验

第六章：HSV 检测市场：依样本类型估算与趋势分析

  • HSV 检测市场：样本类型变异分析
  • 血
  • 棉花棒
  • 脑脊髓液

第七章：HSV检测市场－最终用途、估算与趋势分析

  • HSV检测市场：最终用途差异分析
  • 医院
  • 诊断实验室
  • 诊所及性健康中心
  • 居家医疗/自我检测

8. HSV 检查市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

  • 公司分类
  • 战略地图
    • 新产品发布
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市场占有率分析（2024年）
  • 公司热图分析
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Thermo Fisher Scientific Inc.
    • BD
    • Bio-Rad Laboratories, Inc.
    • BIOMERIEUX
    • DiaSorin SpA
    • Hologic, Inc.
    • Cepheid
    • QuidelOrtho Corporation
Product Code: GVR-4-68040-688-1

HSV Testing Market Summary

The global HSV testing market size was estimated at USD 611.97 million in 2024 and is expected to reach USD 1017.75 million by 2033, growing at a CAGR of 5.96% from 2025 to 2033. This market encompasses diagnostic solutions aimed at the timely and reliable detection of herpes simplex virus types 1 and 2.

Testing platforms in this space range from traditional serological methods to advanced molecular assays, supporting clinical decisions across diverse healthcare environments. These solutions are primarily utilized in managing sexually transmitted infections and prenatal screening, with growing adoption in decentralized and point-of-care settings. The rising incidence of herpes simplex virus infections, along with heightened public awareness and efforts to improve sexual health screening, is supporting market expansion. Integration of HSV testing with digital platforms and remote diagnostic tools is further expanding access to care, particularly in low-resource and underserved settings, enabling earlier detection and timely clinical intervention.

Ongoing advancements in molecular diagnostic technologies are enhancing the sensitivity and turnaround time of HSV testing. Multiplex PCR platforms capable of detecting HSV alongside other sexually transmitted pathogens are gaining clinical preference, particularly in outpatient and emergency care settings. In addition, regulatory approvals for newer test kits with improved sample-to-answer workflows support their use in primary and urgent care environments.

Increased government initiatives and funding for STI surveillance and prevention programs also contribute to market growth. Public health campaigns, especially those targeting adolescent and reproductive health, are driving demand for accessible and accurate HSV testing. Collaborations between public health agencies and private diagnostic providers enable broader test availability, helping reduce diagnostic gaps in developed and resource-limited regions.

Global HSV Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global HSV testing market based on type, test type, sample type, end-use, and region:

  • Type Outlook (USD Million, 2021 - 2033)
  • HSV-1/HSV-2 Combines
  • HSV-1
  • HSV-2
  • Test Type Outlook (USD Million, 2021 - 2033)
  • Serological tests
  • Direct detection tests
    • PCR
    • Viral culture
  • Point-of-care tests
  • Sample Type Outlook (USD Million, 2021 - 2033)
  • Blood
  • Swabs
  • Cerebrospinal fluid
  • End-use Outlook (USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Sexual Health Centers
  • Home care / Self-testing
  • Regional Outlook (USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. HSV Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Test Type Segment
      • 1.1.1.3. Sample Type segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. HSV Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Test Type Snapshot
  • 2.3. Sample Type Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. HSV Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of HSV infections worldwide
    • 3.4.2. Advancements in molecular and point-of-care Testing technologies
    • 3.4.3. Public health initiatives and routine STI screening programs
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited diagnostic accuracy of serological tests
    • 3.5.2. Stigma and underreporting associated with HSV infections
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. HSV Testing Market: Type Estimates & Trend Analysis

  • 4.1. HSV Testing Market: Type Movement Analysis
  • 4.2. HSV-1/HSV-2 Combines
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. HSV-1
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. HSV-2
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. HSV Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. HSV Testing Market: Test Type Movement Analysis
  • 5.2. Serological tests
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Direct detection tests
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. PCR
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Viral culture
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Point-of-care tests
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. HSV Testing Market: Sample Type Estimates & Trend Analysis

  • 6.1. HSV Testing Market: Sample Type Movement Analysis
  • 6.2. Blood
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Swabs
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Cerebrospinal fluid
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. HSV Testing Market: End Use Estimates & Trend Analysis

  • 7.1. HSV Testing Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Clinics and sexual health centers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Home care / self-testing
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. HSV Testing Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America HSV Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA HSV Testing Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait HSV Testing Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. NEW PRODUCT LAUNCH
    • 9.2.2. PARTNERSHIPS
    • 9.2.3. ACQUISITION
    • 9.2.4. COLLABORATION
    • 9.2.5. FUNDING
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. F. Hoffmann-La Roche Ltd.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Abbott
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Thermo Fisher Scientific Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. BD
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Bio-Rad Laboratories, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. BIOMERIEUX
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. DiaSorin S.p.A.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Hologic, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Cepheid
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. QuidelOrtho Corporation
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global HSV Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 5 Global HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 7 Global HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America HSV Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 10 North America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 11 North America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 12 North America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 14 U.S. HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada HSV Testing Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 18 Canada HSV Testing Market, by Type, 2021 - 2033 (USD Million)
  • Table 19 Canada HSV Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 20 Canada HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 24 Mexico HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 27 Europe HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 29 Europe HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 31 UK HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 UK HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 33 UK HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 35 Germany HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 Germany HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 37 Germany HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 39 France HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 France HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 41 France HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 43 Italy HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Italy HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 45 Italy HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 47 Spain HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Spain HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 49 Spain HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 51 Sweden HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 53 Sweden HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 55 Norway HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 57 Norway HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 59 Denmark HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Denmark HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 68 Japan HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 69 Japan HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 70 Japan HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 72 China HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 China HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 74 China HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 76 India HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 77 India HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 78 India HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 80 Australia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 Australia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 82 Australia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 86 Thailand HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 88 South Korea HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 90 South Korea HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 95 Latin America HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 99 Brazil HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 103 Argentina HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA HSV Testing Market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 106 MEA HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 107 MEA HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 108 MEA HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 112 South Africa HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE HSV Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 118 UAE HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 UAE HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 120 UAE HSV Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait HSV Testing Market, by Sample Type, 2021 - 2033 (USD)
  • Table 122 Kuwait HSV Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait HSV Testing Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 124 Kuwait HSV Testing Market, By End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global HSV Testing market- Key market driver analysis
  • Fig. 7 Global HSV Testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global HSV Testing market - Porter's analysis
  • Fig. 10 Global HSV Testing market - PESTEL analysis
  • Fig. 11 Global HSV Testing market Type outlook key takeaways
  • Fig. 12 Global HSV Testing market: Type movement analysis
  • Fig. 13 HSV-1/HSV-2 Combines market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 HSV-1 market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 HSV-2 market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global HSV Testing market test type outlook key takeaways
  • Fig. 17 Global HSV Testing market: test type movement analysis
  • Fig. 18 Serological tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Direct detection tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 PCR market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Viral culture market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Point-of-care tests market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Global HSV Testing market sample type outlook key takeaways
  • Fig. 24 Global HSV Testing market: sample type movement analysis
  • Fig. 25 Blood market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Swabs market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Cerebrospinal fluid market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Global HSV Testing market end use outlook key takeaways
  • Fig. 29 Global HSV Testing market: end use movement analysis
  • Fig. 30 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Clinics and sexual health centers market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Home care / self-Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 Global HSV Testing market: Regional movement analysis
  • Fig. 36 North America HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 38 Canada HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 41 UK HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Germany HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 43 France HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 44 Spain HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 45 Italy HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 48 Norway HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 50 Japan HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 51 China HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 52 India HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 54 Australia HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 59 MEA HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 62 UAE HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait HSV Testing market, 2021 - 2033 (USD Million)
  • Fig. 64 Strategy framework